Terri Brodeur Breast Cancer Foundation Report issue

Foundation Phase 1

Organization Overview

First Clinical Trial
2018
NCT03716180
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Terri Brodeur Breast Cancer Foundation